Welcome to our dedicated page for Right On Brands news (Ticker: RTON), a resource for investors and traders seeking the latest updates and insights on Right On Brands stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Right On Brands's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Right On Brands's position in the market.
Right on Brands, Inc. (OTC PINK:RTON) has partnered with HyperWolf to revolutionize the Texas hemp market. Starting August 15, 2024, HyperWolf will supply Endo Dispensary and Wellness, a Right on Brands company, with a range of premium hemp products including top-shelf flower, pre-rolls, all-in-one vapes, and edibles.
HyperWolf will also launch its direct-to-consumer delivery platform exclusively for Endo stores, offering same-day delivery within 60-90 minutes. The partnership aims to bring California's thriving cannabis community experience to Texas, featuring brand collaborations with top cultivators and exclusive wholesale contracts. This collaboration is set to enhance customer experience, expand market reach, and introduce innovative tools for brand loyalty and industry education.
Right On Brands (OTC PINK:RTON) has named Dr. David M. Snipper as Chief Medical Officer. Dr. Snipper brings over 26 years of medical experience and extensive knowledge in various specializations, including anesthesiology, homeopathy, and wellness.
He will oversee the company's new subsidiary, Right on Med Center, which aims to enhance revenue streams through telemedicine and wellness products. The Med Centers plan to offer peptides like Ozempic and Mounjaro, along with other weight loss therapies and health treatments.
Dr. Snipper aims to work closely with Roy Hammonds, Right On Brands' new CEO, to implement this vision and improve patient well-being post-pandemic.
Right on Brands announced the appointment of Roy Hammonds, a former NBA player, as the new CEO. The company specializes in hemp-based and health products like THCA. Hammonds, with a background in the medical cannabis industry and traditional medicine, is expected to leverage his sports industry contacts and expertise to drive the company's growth. Jerry Grisaffi, the outgoing CEO, expressed confidence in Hammonds' ability to elevate the company.
Right On Brands (OTC PINK:RTON) announced the launch of its new subsidiary, Right on Med Center, and appointed Ron McCormick as its head. McCormick, with 35 years in health, wellness, and fitness, has a background in nutrition stores and training centers. The company plans to open a med center in Dallas and integrate telemedicine portals in its Endo Dispensaries and Wellness stores to expand product sales. Offerings will include peptides like Ozempic, weight loss solutions, and sexual health products. The company aims to have 25 operational stores by the end of 2024, both corporate and franchise.
Right On Brands, Inc. (RTON) is moving to a new 7,200 square foot warehouse and office complex in Fate, Texas to support its accelerated growth plan. The company, known for its hemp-based and THCA products, aims to expand its operations to meet increasing demand. With plans for podcast studios, training facilities, and 25 stores by the end of 2024, RTON is positioning itself for future success.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.